| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,089 |
11,731 |
$1.10M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,278 |
7,495 |
$478K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,198 |
2,057 |
$172K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,503 |
1,426 |
$134K |
| 99407 |
|
3,904 |
3,654 |
$53K |
| 99385 |
|
410 |
369 |
$36K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,003 |
868 |
$29K |
| 81002 |
|
8,646 |
7,925 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,401 |
2,160 |
$20K |
| 81025 |
|
3,089 |
2,807 |
$19K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
256 |
205 |
$16K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,459 |
2,203 |
$14K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
726 |
658 |
$13K |
| 99386 |
|
136 |
108 |
$12K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
181 |
147 |
$11K |
| 99441 |
|
276 |
258 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,148 |
1,006 |
$9K |
| 90686 |
|
500 |
478 |
$8K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
84 |
75 |
$6K |
| 92551 |
|
849 |
709 |
$5K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
369 |
315 |
$4K |
| 99496 |
|
35 |
30 |
$4K |
| 99215 |
Prolong outpt/office vis |
13 |
13 |
$2K |
| 82962 |
|
615 |
571 |
$2K |
| 90733 |
|
65 |
53 |
$1K |
| 93000 |
|
145 |
121 |
$992.35 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
37 |
37 |
$877.83 |
| 99442 |
|
44 |
42 |
$731.23 |
| 86580 |
|
198 |
146 |
$644.69 |
| 94010 |
|
37 |
31 |
$589.12 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
34 |
25 |
$261.78 |
| 1159F |
|
12,298 |
11,094 |
$183.11 |
| 96160 |
|
19 |
16 |
$160.00 |
| 90649 |
|
93 |
70 |
$155.03 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16 |
13 |
$148.25 |
| 82270 |
|
61 |
48 |
$141.75 |
| 1160F |
|
12,483 |
11,245 |
$15.55 |
| 3074F |
|
9,021 |
7,641 |
$6.99 |
| 3011F |
|
6,650 |
6,057 |
$6.86 |
| 3754F |
|
6,529 |
5,817 |
$6.03 |
| 3511F |
|
6,002 |
5,455 |
$5.90 |
| 3078F |
|
7,488 |
6,630 |
$5.61 |
| 4000F |
|
4,842 |
4,502 |
$5.30 |
| 3016F |
|
4,787 |
4,459 |
$5.11 |
| 1008F |
|
5,297 |
4,902 |
$4.78 |
| 3077F |
|
4,824 |
4,367 |
$4.73 |
| 3080F |
|
4,007 |
3,675 |
$4.70 |
| 3079F |
|
4,765 |
4,364 |
$4.63 |
| 3075F |
|
3,017 |
2,824 |
$3.65 |
| 93770 |
|
817 |
788 |
$1.25 |
| 4037F |
|
475 |
446 |
$1.04 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
8,218 |
7,256 |
$0.66 |
| 3061F |
|
4,618 |
4,197 |
$0.63 |
| 3725F |
|
4,866 |
4,502 |
$0.63 |
| 3008F |
|
8,521 |
7,588 |
$0.60 |
| 3352F |
|
206 |
202 |
$0.43 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
24 |
24 |
$0.15 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
24 |
24 |
$0.15 |
| 4015F |
|
182 |
153 |
$0.14 |
| 3015F |
|
495 |
436 |
$0.14 |
| G8473 |
Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed |
3,835 |
3,472 |
$0.08 |
| G8450 |
Beta-blocker therapy prescribed |
804 |
688 |
$0.00 |
| 4086F |
|
1,175 |
1,058 |
$0.00 |
| 90716 |
|
62 |
51 |
$0.00 |
| 1038F |
|
88 |
78 |
$0.00 |
| 90670 |
|
41 |
36 |
$0.00 |
| 90707 |
|
66 |
53 |
$0.00 |
| 4124F |
|
179 |
159 |
$0.00 |
| 90687 |
|
15 |
15 |
$0.00 |
| 90715 |
|
16 |
14 |
$0.00 |
| 90713 |
|
18 |
15 |
$0.00 |
| 90700 |
|
35 |
24 |
$0.00 |
| 90633 |
|
42 |
34 |
$0.00 |